SIMPLE CLOSURE OF PERFORATED DUODENAL ULCER: IS ADDITION TO H2 ANTAGONISTS OF VALUE | ||||
The Egyptian Journal of Surgery | ||||
Volume 19, Issue 1, January 2000, Page 51-53 PDF (119.66 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/ejsur.2000.378701 | ||||
![]() | ||||
Authors | ||||
A. Sibiany* 1; F. Al-Mashat1; A. Kensarah1; A. Meccawy1; M. Kadasi2; G. Wajid2 | ||||
1Department of Surgery, Faculty of Medicine & Allied Sciences, King Abdulaziz University, Jeddah, Saudi Arabia | ||||
2Department of Surgery & Medical Records, King Abdulaziz Hospital & Oncology Centre, Jeddah, Saudi Arabia | ||||
Abstract | ||||
The aim of this study is to evaluate our experience in the treatment of perforated duodenal ulcer. We retrospectively analyzed 50 patients treated with simple closure and postoperative H2-antagonist. Majority of patients (84%) were expatriates. Average age was 34.5 years. No associated medical conditions were reported in any of them. Five patients presented 24 hours after perforation and were in shock. The morbidity was 12%, while there was no death reported. Average hospital stay was 7.4 days. Forty one patients were followed-up for one month to 17 months with no clinical evidence of ulcer recurrence.Conclusion: Simple closure and H2-antagonist resolve peptic ulcer disease with very low morbidity and mortality. IN addition, experience showed that conservative treatment may be appropriate for a selected group of patients where general condition is not deteriorating. | ||||
Keywords | ||||
Perforated duodenal ulcer; simple closure; H2-antagonist | ||||
Statistics Article View: 57 PDF Download: 31 |
||||